Journal of Alzheimer's Disease · Nov 18, 2026

Insulin resistance is associated with lower cerebral myelin content in cognitively unimpaired women across the adult lifespan

By Zhang N, Fox NY, De Rouen A et al.

Background: Insulin resistance (IR) has been implicated in brain aging and Alzheimer's disease (AD), yet its relationship with cerebral myelin content in cognitively unimpaired adults remains unclear, particularly regarding sex differences. Objective: To investigate whether peripheral IR is associated with white matter (WM) myelin content and microstructural integrity in cognitively unimpaired adults, and whether these associations differ by sex. Methods: We used multicomponent relaxometry (n = 125) and diffusion tensor imaging (n = 116) to obtain myelin water fraction (MWF), longitudinal relaxation rate (R1), transverse relaxation rate (R2), and diffusion measures of WM microstructure. Multiple linear regression models adjusted for age, age ² , sex, and IR-by-sex interactions across fifteen WM regions. Results: Higher IR was associated with lower MWF across widespread WM regions, including frontal, temporal, and parietal lobes, corpus callosum, internal capsule, and thalamic radiation. Similar but weaker negative trends were observed for R1, R2, and fractional anisotropy, whereas diffusivity metrics showed opposite but nonsignificant trends. Significant IR-by-sex interactions indicated stronger inverse associations between IR and MWF in women, in whom higher IR was consistently associated with lower MWF across most regions. However, the dynamic range of IR for men was limited. Conclusions: Higher peripheral IR is associated with lower myelin-sensitive WM MRI measures in cognitively unimpaired adults, with stronger associations in women. These findings identify WM myelin alterations as a potential neurobiological correlate of metabolic dysfunction and provide evidence linking peripheral metabolic dysfunction to brain changes relevant to AD pathophysiology. The findings highlight a potential sex-dependent pathway linking metabolic dysfunction to WM alterations associated with AD risk.

doi.org/10.1177/13872877261507268PubMed 43048889Populations

AgingResearch.News